-
From Ibukun Ifelayo on January 14th, 2019
0 likes 9 playsAugust 17, 2018 The Houston Methodist Cancer Symposium is an annual conference dedicated to the science and clinical care of solid and hematologic malignancies. The… -
From Ibukun Ifelayo on September 3rd, 2019
0 likes 19 playsSymposium -
From aasampson@houstonmethodist.org on January 14th, 2019
0 likes 12 playsDay One: September 15, 2018Since the last Cancer Biomarkers Conference, new tests have emerged for predictive biomarkers used to select cancer patients for new… -
From Ibukun Ifelayo on January 14th, 2019
0 likes 14 playsDay Two: September 16, 2018 Since the last Cancer Biomarkers Conference, new tests have emerged for predictive biomarkers used to select cancer patients for new… -
From aasampson@houstonmethodist.org on January 14th, 2019
0 likes 18 playsSince the last Cancer Biomarkers Conference, new tests have emerged for predictive biomarkers used to select cancer patients for new molecular-targeted therapies. New… -
From Ibukun Ifelayo on June 26th, 2020
0 likes 17 playsTreatment of Advanced Lung Cancer 2020: A Case-based Approach May 12, 2020 Eric Bernicker, MD Associate Professor of Clinical Medicine in Oncology, Academic… -
From Ibukun Ifelayo on September 10th, 2019
0 likes 7 playsWednesday | July 31, 2019 Noon – 1 p.m. Houston Methodist Research Institute Ernest H. Cockrell Boardroom (R2-311) Our era of big data biomedicine presents… -
From Ibukun Ifelayo on March 9th, 2020
0 likes 12 playsGlobal Leadership conversations with Jenny Chang, MD 03.02.20 -
From Ibukun Ifelayo on June 23rd, 2020
0 likes 5 playsHong Zhao MD, PhDAssistant Professor of Molecular Biology in OncologyCo-Director of Advanced Cellular and Tissue Microscope Core Houston Methodist Cancer CenterUp to 40%… -
From Ibukun Ifelayo on August 4th, 2020
0 likesAgenda: Click here View Disclosures/CE Info: Click here Visit the Virtual Exhibit Hall: Click here Visit the Virtual Abstract Hall: Click here Submit Questions to the… -
From Ibukun Ifelayo on August 22nd, 2020
0 likes 2 playsEvaluating efficacy of tocilizumab for a subtype of triple negative Breast cancer that resists Chemotherapy via an autocrine IL-1A mediated self-induction of IL-6 -
From Ibukun Ifelayo on August 20th, 2020
0 likes 1 playsMyeloproliferative Neoplasms: Science and Practice -
From Ibukun Ifelayo on August 20th, 2020
0 likes 2 playsLiquid Biopsies and Management of Advanced Lung Cancer -
From Ibukun Ifelayo on August 22nd, 2020
0 likes 23 playsDevelopment Of Implantable Artificial Lymph Node as Therapeutic Cancer Vaccine -
From Ibukun Ifelayo on August 20th, 2020
0 likes 4 playsLung Cancer and Oncolytic Viruses -
From Ibukun Ifelayo on August 20th, 2020
0 likes 3 playsOverview of Cancer Center -
From Ibukun Ifelayo on August 20th, 2020
0 likes 2 playsInvolving Patients in Advancing Research and Advocacy through Communication and Collaboration -
From Ibukun Ifelayo on August 20th, 2020
0 likes 2 playsAllogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Who, When and How? -
From Ibukun Ifelayo on August 20th, 2020
0 likes 2 playsBeyond Ruxolitnib: Novel Agents and Combinations for Myelofibrosis -
From Ibukun Ifelayo on August 22nd, 2020
0 likes 1 playsCytology and Management of Small Biopsies in Lung Cancer
© 2021. Houston Methodist, Houston, TX. All rights reserved. | Website Privacy Disclaimer User Guides and Technical Documentation